ESPR
ESPR
US29664W1053
Esperion Therapeutics, Inc.
Loading chart...

Company Profile

-

Latest News

ECOS warns ESPR risks over-relying on consumer data in green fashion push

Related stocks

AMPH
AMPH • United States
Amphastar Pharmaceuticals, Inc.
26.62 USD
1.13B USD 1Y -0.7%
COLL
COLL • United States
Collegium Pharmaceutical, Inc.
22.09 USD
719.15M USD 1Y -33.3%
GTII.CN
GTII.CN • United States
GreenThumb
9.58 CAD
1.47B USD 1Y -21.2%
EOLS
EOLS • United States
Evolus, Inc. Common Stock
7.73 USD
510.57M USD 1Y +25.6%
ETON
ETON • United States
Eton Pharmaceuticals, Inc.
55.21 USD
1.58B USD 1Y +161.6%
AQST
AQST • United States
Aquestive Therapeutics, Inc.
4.78 USD
599.95M USD 1Y -23.2%
XERS
XERS • United States
Xeris Biopharma Holdings, Inc.
10.48 USD
1.91B USD 1Y +24.3%
IRWD
IRWD • United States
Ironwood Pharmaceuticals, Inc.
3.82 USD
631.22M USD 1Y +144.9%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
4 Metrics
Country
United States
Region
North America
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

6/7 High
3Y Volatility
-
Max Drawdown (3Y)
-
Sharpe Ratio (3Y)
-
Beta Factor
1.06
Size Class
Small Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
ende